US Stock MarketDetailed Quotes

RVPH Reviva Pharmaceuticals

Watchlist
  • 1.120
  • -0.030-2.61%
Close Nov 26 16:00 ET
  • 1.160
  • +0.040+3.56%
Post 16:37 ET
37.45MMarket Cap-1037P/E (TTM)

Reviva Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
31.36%-4.24M
-59.41%-8.48M
-47.47%-11.73M
-49.39%-28.32M
-89.24%-8.88M
-54.41%-6.18M
-32.89%-5.32M
-26.88%-7.95M
-77.73%-18.96M
-20.21%-4.69M
Net income from continuing operations
26.27%-8.37M
32.87%-7.86M
-8.49%-7.43M
-38.92%-39.26M
22.30%-9.36M
-222.76%-11.35M
-119.22%-11.71M
6.97%-6.85M
-231.63%-28.26M
-226.75%-12.04M
Operating gains losses
48.00%-72.32K
-143.90%-200.27K
-4,000.10%-456.18K
22.86%239.22K
-114.46%-66.76K
---139.08K
356.25%456.18K
87.50%-11.13K
112.24%194.71K
266.00%461.74K
Depreciation and amortization
----
----
--0
----
----
----
----
--0
----
----
Change In working capital
-22.33%3.85M
-123.39%-774.99K
-268.83%-4.21M
-18.43%7.28M
-97.73%154.98K
1,039.80%4.96M
124.25%3.31M
-199.35%-1.14M
1,371.68%8.93M
16,759.26%6.83M
-Change in prepaid assets
-171.30%-196.56K
-136.79%-351.51K
4.19%-1.19M
-94.60%70.89K
-65.58%81.81K
-33.18%275.7K
73.18%955.53K
-1,227.05%-1.24M
176.55%1.31M
116.83%237.65K
-Change in payables and accrued expense
-13.56%4.05M
-117.96%-423.48K
-3,054.68%-3.02M
-5.31%7.21M
-98.89%73.17K
597.89%4.68M
154.69%2.36M
-90.16%102.04K
652.64%7.62M
380.91%6.59M
Cash from discontinued investing activities
Operating cash flow
31.36%-4.24M
-59.41%-8.48M
-47.47%-11.73M
-49.39%-28.32M
-89.24%-8.88M
-54.41%-6.18M
-32.89%-5.32M
-26.88%-7.95M
-77.73%-18.96M
-20.21%-4.69M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
3.62M
-48.58%2.68M
-51.68%332K
325.69%33.17M
146,813.77%27.27M
0
5.21M
981,461.43%687.09K
-75.34%7.79M
-81.15%18.56K
Net issuance payments of debt
---124.5K
72.02%-124.5K
-50.26%332K
--0
---222.5K
--0
---445K
--667.5K
--0
--0
Net common stock issuance
--3.75M
----
----
253.69%27.49M
--27.49M
--0
----
----
-75.32%7.77M
--0
Proceeds from stock option exercised by employees
--35
--0
--0
29,836.99%5.68M
--0
--0
--5.66M
27,890.00%19.59K
-80.74%18.97K
-81.15%18.56K
Cash from discontinued financing activities
Financing cash flow
--3.62M
-48.58%2.68M
-51.68%332K
325.69%33.17M
146,813.77%27.27M
--0
--5.21M
981,461.43%687.09K
-75.34%7.79M
-81.15%18.56K
Net cash flow
Beginning cash position
-44.60%6.18M
6.38%11.97M
26.18%23.37M
-37.62%18.52M
-78.56%4.97M
-42.58%11.15M
-51.94%11.26M
-37.62%18.52M
238.89%29.69M
-30.75%23.19M
Current changes in cash
89.98%-619.36K
-5,474.17%-5.8M
-56.85%-11.39M
143.41%4.85M
493.73%18.4M
-263.83%-6.18M
97.40%-103.97K
-15.92%-7.26M
-153.37%-11.17M
-22.83%-4.67M
End cash Position
11.80%5.56M
-44.60%6.18M
6.38%11.97M
26.18%23.37M
26.18%23.37M
-78.56%4.97M
-42.58%11.15M
-51.94%11.26M
-37.62%18.52M
-37.62%18.52M
Free cash flow
31.36%-4.24M
-59.41%-8.48M
-47.47%-11.73M
-49.39%-28.32M
-89.24%-8.88M
-54.41%-6.18M
-32.89%-5.32M
-26.88%-7.95M
-77.73%-18.96M
-20.21%-4.69M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 31.36%-4.24M-59.41%-8.48M-47.47%-11.73M-49.39%-28.32M-89.24%-8.88M-54.41%-6.18M-32.89%-5.32M-26.88%-7.95M-77.73%-18.96M-20.21%-4.69M
Net income from continuing operations 26.27%-8.37M32.87%-7.86M-8.49%-7.43M-38.92%-39.26M22.30%-9.36M-222.76%-11.35M-119.22%-11.71M6.97%-6.85M-231.63%-28.26M-226.75%-12.04M
Operating gains losses 48.00%-72.32K-143.90%-200.27K-4,000.10%-456.18K22.86%239.22K-114.46%-66.76K---139.08K356.25%456.18K87.50%-11.13K112.24%194.71K266.00%461.74K
Depreciation and amortization ----------0------------------0--------
Change In working capital -22.33%3.85M-123.39%-774.99K-268.83%-4.21M-18.43%7.28M-97.73%154.98K1,039.80%4.96M124.25%3.31M-199.35%-1.14M1,371.68%8.93M16,759.26%6.83M
-Change in prepaid assets -171.30%-196.56K-136.79%-351.51K4.19%-1.19M-94.60%70.89K-65.58%81.81K-33.18%275.7K73.18%955.53K-1,227.05%-1.24M176.55%1.31M116.83%237.65K
-Change in payables and accrued expense -13.56%4.05M-117.96%-423.48K-3,054.68%-3.02M-5.31%7.21M-98.89%73.17K597.89%4.68M154.69%2.36M-90.16%102.04K652.64%7.62M380.91%6.59M
Cash from discontinued investing activities
Operating cash flow 31.36%-4.24M-59.41%-8.48M-47.47%-11.73M-49.39%-28.32M-89.24%-8.88M-54.41%-6.18M-32.89%-5.32M-26.88%-7.95M-77.73%-18.96M-20.21%-4.69M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 3.62M-48.58%2.68M-51.68%332K325.69%33.17M146,813.77%27.27M05.21M981,461.43%687.09K-75.34%7.79M-81.15%18.56K
Net issuance payments of debt ---124.5K72.02%-124.5K-50.26%332K--0---222.5K--0---445K--667.5K--0--0
Net common stock issuance --3.75M--------253.69%27.49M--27.49M--0---------75.32%7.77M--0
Proceeds from stock option exercised by employees --35--0--029,836.99%5.68M--0--0--5.66M27,890.00%19.59K-80.74%18.97K-81.15%18.56K
Cash from discontinued financing activities
Financing cash flow --3.62M-48.58%2.68M-51.68%332K325.69%33.17M146,813.77%27.27M--0--5.21M981,461.43%687.09K-75.34%7.79M-81.15%18.56K
Net cash flow
Beginning cash position -44.60%6.18M6.38%11.97M26.18%23.37M-37.62%18.52M-78.56%4.97M-42.58%11.15M-51.94%11.26M-37.62%18.52M238.89%29.69M-30.75%23.19M
Current changes in cash 89.98%-619.36K-5,474.17%-5.8M-56.85%-11.39M143.41%4.85M493.73%18.4M-263.83%-6.18M97.40%-103.97K-15.92%-7.26M-153.37%-11.17M-22.83%-4.67M
End cash Position 11.80%5.56M-44.60%6.18M6.38%11.97M26.18%23.37M26.18%23.37M-78.56%4.97M-42.58%11.15M-51.94%11.26M-37.62%18.52M-37.62%18.52M
Free cash flow 31.36%-4.24M-59.41%-8.48M-47.47%-11.73M-49.39%-28.32M-89.24%-8.88M-54.41%-6.18M-32.89%-5.32M-26.88%-7.95M-77.73%-18.96M-20.21%-4.69M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data